SCHEMBL23735852

SCHEMBL23735852

CC(C)N1CCNCC1(C)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12339300 0.74 SOS1 (0.33) —
SCHEMBL21725612 0.71 — —
Hydrochloric Acid SCHEMBL3138631 0.69 SOS1 (0.31) —
Hydrochloric Acid SCHEMBL3130639 0.69 SOS1 (0.31) —
SCHEMBL17789639 0.68 SOS1 (0.45) —
SCHEMBL757660 0.68 SOS1 (0.32) —
SCHEMBL20314968 0.68 — —
SCHEMBL27656844 0.67 SOS1 (0.31) —
SCHEMBL27443832 0.65 SOS1 (0.52) —
SCHEMBL6743419 0.65 SOS1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3558955-B1 BENZISOTHIAZOLE, ISOTHIAZOLO[3,4-B]PYRIDINE, QUINAZOLINE, PHTHALAZINE, PYRIDO[2,3-D]PYRIDAZINE AND PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG, PANCREATIC OR COLORECTAL CANCER AMGEN INC (US) 2021-08-11 — — EP disclosed
Send feedback